ORTX
Orchard Therapeutics plc American Depositary Shares
ORTX
ORTX
Delisted
ORTX was delisted on the 23rd of January, 2024.
47 hedge funds and large institutions have $122M invested in Orchard Therapeutics plc American Depositary Shares in 2023 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
99% less call options, than puts
Call options by funds: $26K | Put options by funds: $2.07M
Holders
47
Holding in Top 10
1
Calls
$26K
Puts
$2.07M
Top Buyers
| 1 | +$25.7M | |
| 2 | +$5.47M | |
| 3 | +$4.93M | |
| 4 |
Millennium Management
New York
|
+$3.93M |
| 5 |
GF
Gabelli Funds
Rye,
New York
|
+$3.69M |
Top Sellers
| 1 | -$2.44M | |
| 2 | -$1.92M | |
| 3 | -$1.49M | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$936K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$739K |